Adapting a machine learning algorithm to predict thyroid cytopathologyin LMIC
Adapting a machine learning algorithm to predict thyroid cytopathologyin LMIC
批准号:
10269391
负责人:
WALTER Tsong LEE
金额:
$20.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-08-01 至 2023-07-31
关键词:
ArchivesAreaAsiansBiopsy SpecimenCellular PhoneCessation of lifeClinicalClinical TrialsClinical assessmentsCountryCytopathologyDataDiagnosisDiseaseEarly DiagnosisEquipmentFinancial costFine needle aspiration biopsyFundingFutureGoalsHealthHuman ResourcesImageImprove AccessIncidenceInstitutionInternationalIodineLaboratoriesMachine LearningMalignant NeoplasmsMalignant neoplasm of thyroidMethodsMicroscopeNoduleOperative Surgical ProceduresOutcomeOutcome MeasurePathologistPathologyPatient CarePatientsPhasePlayPopulationPreparationProbabilityProceduresProtocols documentationReportingResearchResolutionResourcesRiskRisk FactorsRoleSamplingSensitivity and SpecificityServicesSlideSpecimenStainsStressSystemTanzaniaTestingThyroid GlandThyroid NoduleTimeTrainingTriageUltrasonographyUnnecessary SurgeryVietnambaseclinical careclinical decision-makingcostcost effectivedigitalhandheld mobile deviceimprovedinterestlow and middle-income countriesmachine learning algorithmmultidisciplinaryprospectivepublic health relevancestandard of care
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Pathology expertise and services in low and middle income countries (LMIC) are severely inadequate and
limited. One area in which pathology is especially critical for diagnosis and clinical decision making is thyroid
related disease and cancers. The incidences of thyroid nodules and cancers have increased worldwide. A
fundamental part of the clinical assessment for thyroid nodules is ultrasound-guided fine needle aspiration biopsy
(FNAB). Unfortunately, this cytopathology expertise is scarce in LMIC and many nodules are surgically removed
for diagnosis. Since 90-95% of these nodules are without malignancy, many patients undergo unnecessary
surgery with the associated risks, financial costs, and stressing already limited resources. What is critically
needed is a means to provide cytopathology expertise to interpret thyroid FNAB in LMIC.
The overall goal of this proposal is to implement our ML approach into low resource settings to provide
accurate and timely cytopathology analysis of FNAB specimens. This R21/33 proposal focuses on MLA
adaptation using smartphones for LMIC (R21) and subsequent capacity building and implementation (R33)
through well-established LMIC research partnerships in tertiary centers in Tanzania and Vietnam. We
hypothesize that our MLA can use smartphone captured images to assess probability of malignancy in thyroid
FNAB that is comparable to trained cytopathologists.
Our Aims are: R21: Adaptation of a smartphone approach to capture cytopathology images for MLA analysis.
Archived FNAB samples used at different international institutions will be used to train and adapt the MLA with
these images. Furthermore, we would train local personnel in LMIC to image capture using this new setup. The
results from this phase will be an adapted MLA using smartphone images that has comparable sensitivity and
specificity to the original MLA. R33: Implementation of the smartphone MLA approach into LMIC clinical settings.
A prospective implementation of this approach in tertiary centers in Tanzania and Vietnam will be conducted.
FNAB samples obtained would undergo standard of care pathology assessment as well as be analyzed with the
MLA protocol. Local cytopathologist assessment will be compared with the MLA analysis. Outcome measures
include MLA assessment of slides, technical slide review and image capture, concordance with pathology
between MLA and expertise both in US and LMIC.
The expected outcome will lead to a cost-effective method to implement MLA for thyroid FNAB that can be used
in LMIC. This approach will not only assist in early diagnosis of thyroid cancers but also improve the utilization
of limited resources through effectively identifying those that need surgery from those that do not.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RAPID System for Early Detection of Head and Neck Cancer in Low-Resource Settings
-
批准号:10444593
-
项目类别:
-
资助金额:$56.01万
-
财政年份:2022
-
负责人:WALTER Tsong LEE
-
依托单位:
RAPID System for Early Detection of Head and Neck Cancer in Low-Resource Settings
-
批准号:10580036
-
项目类别:
-
资助金额:$54.14万
-
财政年份:2022
-
负责人:WALTER Tsong LEE
-
依托单位:
Adapting a machine learning algorithm to predict thyroid cytopathologyin LMIC
-
批准号:10458057
-
项目类别:
-
资助金额:$18.76万
-
财政年份:2021
-
负责人:WALTER Tsong LEE
-
依托单位:
Partnership to establish a practice based network to assess for head and neck cancers using a low-cost portable flexible nasopharyngoscope
-
批准号:10620741
-
项目类别:
-
资助金额:$53.57万
-
财政年份:2019
-
负责人:WALTER Tsong LEE
-
依托单位:
Covid-19 PPE for LMIC
-
批准号:10295570
-
项目类别:
-
资助金额:$4.58万
-
财政年份:2019
-
负责人:WALTER Tsong LEE
-
依托单位:
Partnership to establish a practice based network to assess for head and neck cancers using a low-cost portable flexible nasopharyngoscope
-
批准号:10405078
-
项目类别:
-
资助金额:$55.98万
-
财政年份:2019
-
负责人:WALTER Tsong LEE
-
依托单位:
Augmenting immune responses to DC-tumor fusions using local 3rd signals
-
批准号:8698285
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:WALTER Tsong LEE
-
依托单位:
Augmenting immune responses to DC-tumor fusions using local 3rd signals
-
批准号:8312342
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:WALTER Tsong LEE
-
依托单位:
Augmenting immune responses to DC-tumor fusions using local 3rd signals
-
批准号:8142497
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:WALTER Tsong LEE
-
依托单位:
Augmenting immune responses to DC-tumor fusions using local 3rd signals
-
批准号:8402122
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:WALTER Tsong LEE
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: